Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-0.02%Buyback Yield
VS
Market
Sector
Industry
History
$ 4.41Close
$ 2.58 - $ 5.4 52-Week Range
Ticker Information
Ticker
LTRNCompany Name
LANTERN PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLANTERN PHARMA INC - Buyback Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LTRN - Buyback Yield Historical data
| Date | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|---|---|
| 6/30/2025 | -0.02% | $ 51.41M | $ 11.99K |
| 3/31/2025 | -0.03% | $ 41.63M | $ 11.99K |
| 12/31/2024 | -0.17% | $ 40.12M | $ 66.71K |
| 9/30/2024 | 1.17% | $ 36.88M | $ -433.29K |
| 6/30/2024 | 0.98% | $ 45.53M | $ -445.28K |
| 3/31/2024 | 0.61% | $ 73.27M | $ -445.28K |
| 12/31/2023 | 0.47% | $ 106.98M | $ -500K |
| 9/30/2023 | 0.99% | $ 30.43M | $ -299.79K |
| 6/30/2023 | 0.59% | $ 50.76M | $ -299.79K |
| 3/31/2023 | 0.49% | $ 60.8M | $ -299.79K |
Key Performance Insights, Last 5 Years
- LANTERN PHARMA INC's latest trailing twelve months (TTM) Buyback Yield stands at 0%.
- Over the past 5 years, LANTERN PHARMA INC's average Buyback Yield has been -12.94%.
- The median Buyback Yield for LANTERN PHARMA INC during this period was 0.49%
- LANTERN PHARMA INC reached its highest Buyback Yield over the past 5 years at 6.58%.
- The lowest Buyback Yield recorded by LANTERN PHARMA INC in the same timeframe -96.39%
Similar metrics to CF - Equity:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
Definition of Buyback Yield
[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.(-1 * CF - Equity) / Market Cap
(=) Buyback Yield Buyback Yield for LANTERN PHARMA INC is calculated as follows: (-1 * CF - Equity [ $ 0 ]) / Market Cap [ $ 94.82M ]
(=) Buyback Yield [ 0% ] LTRN - Buyback Yield, Last 5 years
-96.39%
Minimum
Dec 31, 2021
6.58%
Maximum
Sep 30, 2022
-12.94%
Average
0.49%
Median
Buyback Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -8.43% |
| max | 8.43% |
| average | 0.64% |
| median | 0.01% |
| std | 2.71% |